Unravel Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-02-19
- Employees
- 1
- Market Cap
- -
- Website
- http://www.unravel.bio
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Pitt Hopkins Syndrome
Not Applicable
Not yet recruiting
- Conditions
- Pitt Hopkins Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-09-02
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- Unravel Biosciences, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT07150026
- Locations
- 🇨🇴
Grupo de Investigación Clínica PECET (GIC-PECET), Medellín, Colombia
Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome
Not Applicable
Not yet recruiting
- Conditions
- Rett Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-09-02
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- Unravel Biosciences, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT07150013
- Locations
- 🇨🇴
Grupo de Investigación Clínica PECET (GIC-PECET), Medellín, Colombia
News
No news found